Jiangsu Kanion Pharmaceutical Co (SHSE:600557) Cyclically Adjusted Book per Share: ¥7.41 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600557 Jiangsu Kanion Pharmaceutical Co Ltd SHSE:600557
82 GF Score
Price ¥12.96
GF Value ¥13.70
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Jiangsu Kanion Pharmaceutical Co Cyclically Adjusted Book per Share?

Jiangsu Kanion Pharmaceutical Co SHSE:600557 -4.92% 82 Cyclically Adjusted Book per Share is ¥7.41 as of Mar. 2026. GuruFocus rates SHSE:600557 with a GF Score™ of 82/100 and a GF Value™ of ¥13.70 (Fairly Valued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Jiangsu Kanion Pharmaceutical Co's adjusted book value per share for the three months ended in Mar. 2026 was ¥8.651. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥7.41 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Jiangsu Kanion Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 5.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 6.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 8.40% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Jiangsu Kanion Pharmaceutical Co was 17.90% per year. The lowest was 6.90% per year. And the median was 14.55% per year.

As of today (2026-07-16), Jiangsu Kanion Pharmaceutical Co's current stock price is ¥12.96. Jiangsu Kanion Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ¥7.41. Jiangsu Kanion Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 1.75.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Jiangsu Kanion Pharmaceutical Co was 6.97. The lowest was 1.47. And the median was 2.87.


Jiangsu Kanion Pharmaceutical Co  (SHSE:600557) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Jiangsu Kanion Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=12.96/7.41
=1.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Jiangsu Kanion Pharmaceutical Co was 6.97. The lowest was 1.47. And the median was 2.87.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Jiangsu Kanion Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Jiangsu Kanion Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Jiangsu Kanion Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Kanion Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Jiangsu Kanion Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.40 5.97 6.45 6.91 7.30

Jiangsu Kanion Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.01 7.08 7.19 7.30 7.41

SHSE:600557 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Kanion Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Kanion Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Kanion Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Jiangsu Kanion Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


SHSE:600557
82GF Score
Jiangsu Kanion Pharmaceutical Co Ltd SHSE:600557
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangsu Kanion Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Jiangsu Kanion Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=8.651/116.3033*116.3033
=8.651

Current CPI (Mar. 2026) = 116.3033.

Jiangsu Kanion Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 4.803 101.400 5.509
201609 4.968 102.400 5.643
201612 5.099 102.600 5.780
201703 5.240 103.200 5.905
201706 5.350 103.100 6.035
201709 5.527 104.100 6.175
201712 5.654 104.500 6.293
201803 5.808 105.300 6.415
201806 5.921 104.900 6.565
201809 6.109 106.600 6.665
201812 6.309 106.500 6.890
201903 6.316 107.700 6.821
201906 6.207 107.700 6.703
201909 6.428 109.800 6.809
201912 6.639 111.200 6.944
202003 6.775 112.300 7.017
202006 6.803 110.400 7.167
202009 6.906 111.700 7.191
202012 7.028 111.500 7.331
202103 7.068 112.662 7.296
202106 7.061 111.769 7.347
202109 7.074 112.215 7.332
202112 7.260 113.108 7.465
202203 7.658 114.335 7.790
202206 7.834 114.558 7.953
202209 7.844 115.339 7.910
202212 8.132 115.116 8.216
202303 8.374 115.116 8.460
202306 8.425 114.558 8.553
202309 8.551 115.339 8.623
202312 8.448 114.781 8.560
202403 9.156 115.227 9.242
202406 8.849 114.781 8.966
202409 8.852 115.785 8.892
202412 7.760 114.893 7.855
202503 8.074 115.116 8.157
202506 8.226 114.907 8.326
202509 8.327 115.471 8.387
202512 8.511 115.832 8.546
202603 8.651 116.303 8.651

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥7.41 mean?
Jiangsu Kanion Pharmaceutical Co (SHSE:600557) has a Cyclically Adjusted Book per Share of ¥7.41 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Jiangsu Kanion Pharmaceutical Co and its competitors.
Is Jiangsu Kanion Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Jiangsu Kanion Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥7.41. Overall, Jiangsu Kanion Pharmaceutical Co has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Kanion Pharmaceutical Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Jiangsu Kanion Pharmaceutical Co's Cyclically Adjusted Book per Share of ¥7.41 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Jiangsu Kanion Pharmaceutical Co and its competitors. Jiangsu Kanion Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥7.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Kanion Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Kanion Pharmaceutical Co (SHSE:600557) is currently considered Fairly Valued. The stock's GF Value™ is ¥13.70, compared to a current price of ¥12.96 — trading 5.4% below its estimated fair value. The current Cyclically Adjusted Book per Share is ¥7.41. Jiangsu Kanion Pharmaceutical Co's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Jiangsu Kanion Pharmaceutical Co (SHSE:600557), the current Cyclically Adjusted Book per Share is ¥7.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jiangsu Kanion Pharmaceutical Co (SHSE:600557) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangsu Kanion Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥12.96 is trading 5.4% below its estimated GF Value™ of ¥13.70. GuruFocus considers Jiangsu Kanion Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:600557:

  • Cyclically Adjusted Book per Share: ¥7.41
  • GF Value™: ¥13.70 vs. price of ¥12.96 (5.4% below fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600557 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jiangsu Kanion Pharmaceutical Co Business Description

Address No. 58 Haichang South Road, Xinpu District, Jiangsu, Lianyungang, CHN, 222001
Jiangsu Kanion Pharmaceutical Co Ltd focuses on R&D, production and trade of traditional Chinese medicine. The company also makes orthopedics, cardiovascular, anti-infective and anti-tumor products.
82GF Score

Get the complete analysis for SHSE:600557

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥12.96
Price
¥13.70
GF Value